Latest Headlines

  1. LabConnect Launches SampleGISTICS® 2.0 To Digitize Clinical Trial Sample Capture 3/31/2026

    LabConnect, a global provider of central laboratory services and functional service provider solutions for clinical trials, today announced the launch of SampleGISTICS® 2.0, an application that enables clinical research sites to scan, record and transmit participant sample information.

  2. Takara Bio USA And Hamilton Company Partner To Automate NGS Library Preparation 3/30/2026

    Takara Bio USA, Inc., a wholly owned subsidiary of Takara Bio Inc., and Hamilton Company announced a development and co-marketing agreement to deliver integrated, automated next-generation sequencing (NGS) library preparation workflows to laboratories worldwide.

  3. Ataraxis AI Launches Ataraxis Breast CTX, The First Predictive AI Test Estimating Individualized Chemotherapy Benefit In Breast Cancer 3/30/2026

    Ataraxis AI, a frontier artificial intelligence (AI) research lab developing AI-powered tools for oncology, today announced Ataraxis Breast CTX, a new predictive capability within its Ataraxis Breast platform, designed to help estimate individualized chemotherapy benefit in breast cancer patients.

  4. Lunit, CellCarta Announce Strategic Collaboration To Accelerate AI-Enabled Digital Pathology For Companion Diagnostic Programs 3/30/2026

    Lunit (KRX: 328130), a leading provider of AI for cancer diagnostics and precision oncology, and CellCarta, a leading global contract research organization (CRO) laboratory to the biopharmaceutical industry, today announced a strategic partnership to accelerate adoption of AI-enabled digital pathology workflows across translational research, clinical trials and companion diagnostic (CDx) programs.

  5. Roche Receives FDA 510(k) Clearance For Cobas® C703 And Cobas® ISE Neo, Next-Generation Analytical Units Enhancing Efficiency And Capability For Laboratories 3/30/2026

    Roche announced today the U.S. Food and Drug Administration (FDA) 510(k) clearance of its newest analytical units – the cobas® c 703 and cobas® ISE neo.

  6. Scispot Launches Labforms™ To Capture External Lab Data As Structured, Audit-Ready Records 3/27/2026

    Scispot has launched Labforms, a form builder designed for life science labs that need to collect data from external partners and bring it directly into their internal systems.

  7. STEMart Expands Comprehensive Portfolio Of High-Performance Chromatography Columns For Precision Laboratory Separations 3/26/2026

    STEMart, a US-based provider of comprehensive services for all phases of medical device development, has announced the expansion of its product line with the launch of Chromatography Columns.

  8. Eurofins Viracor Launches ExPeCT™ anti-CD19 (obe-cel) CAR T-Cell Assay To Advance Proactive Monitoring In Next-Generation Immunotherapy 3/26/2026

    Eurofins Viracor, a leader in advanced clinical diagnostics, today announced the launch of the ExPeCT™ anti-CD19 (obe-cel) CAR T-cell assay, a cutting-edge solution designed to help clinicians monitor CAR T-cell therapy performance with validated precision and a quick turn-around-time for results.

  9. StarLIMS To Acquire The MODA Platform From Lonza, Expanding Deeper Into Manufacturing Operations & Quality Control 3/25/2026

    StarLIMS has agreed to acquire the MODA Platform, a trusted solution for manufacturing quality assurance and control in regulated environments. The transaction is expected to close in Q2 2026, subject to customary closing conditions.

  10. CorePlus And Ibex Expand Partnership With Clinical Deployment Of AI-Powered Diagnostics For TURP 3/25/2026

    CorePlus Servicios Clínicos y Patológicos, LLC (CorePlus), a high-complexity CLIA-certified laboratory and global leader in digital transformation, and Ibex Medical Analytics (Ibex), a pioneer in AI-powered cancer diagnostics, today announced the first clinical deployment of Ibex Prostate for Transurethral Resection of the Prostate (TURP), an AI solution for rapid, high-volume diagnostic support.